Article info
Healthcare delivery, economics and global health
Original article
Cost-effectiveness of the polypill versus risk assessment for prevention of cardiovascular disease
- Correspondence to Dr Steffen E Petersen, National Institute for Health Research Cardiovascular Biomedical Research Unit at Barts, William Harvey Research Institute, Queen Mary University of London, Charterhouse Square, London, EC1M 6BQ, UK; s.e.petersen{at}qmul.ac.uk
Citation
Cost-effectiveness of the polypill versus risk assessment for prevention of cardiovascular disease
Publication history
- Received August 27, 2016
- Revised November 29, 2016
- Accepted December 2, 2016
- First published January 11, 2017.
Online issue publication
March 13, 2017
Article Versions
- Previous version (11 January 2017).
- You are viewing the most recent version of this article.
Request permissions
If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.
Copyright information
Published by the BMJ Publishing Group Limited. For permission to use (where not already granted under a licence) please go to http://www.bmj.com/company/products-services/rights-and-licensing/